Nitric oxide (NO) signalling plays an important role in the integration of information processed by the basal ganglia nuclei. Accordingly, considerable evidence has emerged indicating a role for NO in pathophysiological conditions such as Parkinson’s disease (PD), schizophrenia and drug addiction. To further investigate the NO modulation of dopaminergic function in the basal ganglia circuitry, in this study we used in vivo electrophysiology and microdialysis in freely-moving rats. Pharmacological manipulation of the NO system did not cause any significant changes either in the basal firing rate and bursting activity of the dopamine (DA) neurons in the substantia nigra pars compacta (SNc) or in DA release in the striatum. In contrast, the disruption of endogenous NO tone was able to counteract the phasic dopaminergic activation induced by nicotine treatment in both experimental approaches. These results further support the possibility that nicotine acts via a NO mechanism and suggest a possible state-dependent facilitatory control of NO on the nigrostriatal DA pathway. Thus, NO selectively modulates the DA exocytosis associated with increased DA function

Di Matteo, V., Pierucci, M., Benigno, A., Esposito, E., Crescimanno, G., Casarrubea, M., et al. (2009). Nitric Oxide modulation of the dopaminergic nigrostriatal system: focus on nicotine action.. In H.J. Groenewegen, P. Voorn, H.W. Berendse, A.a.C.A. Mulder (a cura di), The Basal Ganglia IX (pp. 309-321). Springer New York, NY [10.1007/978-1-4419-0340-2_24].

Nitric Oxide modulation of the dopaminergic nigrostriatal system: focus on nicotine action.

BENIGNO, Arcangelo;CRESCIMANNO, Giuseppe;CASARRUBEA, Maurizio;
2009-01-01

Abstract

Nitric oxide (NO) signalling plays an important role in the integration of information processed by the basal ganglia nuclei. Accordingly, considerable evidence has emerged indicating a role for NO in pathophysiological conditions such as Parkinson’s disease (PD), schizophrenia and drug addiction. To further investigate the NO modulation of dopaminergic function in the basal ganglia circuitry, in this study we used in vivo electrophysiology and microdialysis in freely-moving rats. Pharmacological manipulation of the NO system did not cause any significant changes either in the basal firing rate and bursting activity of the dopamine (DA) neurons in the substantia nigra pars compacta (SNc) or in DA release in the striatum. In contrast, the disruption of endogenous NO tone was able to counteract the phasic dopaminergic activation induced by nicotine treatment in both experimental approaches. These results further support the possibility that nicotine acts via a NO mechanism and suggest a possible state-dependent facilitatory control of NO on the nigrostriatal DA pathway. Thus, NO selectively modulates the DA exocytosis associated with increased DA function
2009
Settore BIO/09 - Fisiologia
Di Matteo, V., Pierucci, M., Benigno, A., Esposito, E., Crescimanno, G., Casarrubea, M., et al. (2009). Nitric Oxide modulation of the dopaminergic nigrostriatal system: focus on nicotine action.. In H.J. Groenewegen, P. Voorn, H.W. Berendse, A.a.C.A. Mulder (a cura di), The Basal Ganglia IX (pp. 309-321). Springer New York, NY [10.1007/978-1-4419-0340-2_24].
File in questo prodotto:
File Dimensione Formato  
2009d - IBAGS IX.pdf

Solo gestori archvio

Dimensione 671.19 kB
Formato Adobe PDF
671.19 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/38920
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 0
social impact